Gujarat Themis (GUJTHEM) | Financial Analysis & Statements
Gujarat Themis Biosyn Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2025Income Metrics
Revenue
423.5M
Gross Profit
349.1M
82.44%
Operating Income
179.8M
42.47%
Net Income
142.6M
33.68%
EPS (Diluted)
₹1.31
Balance Sheet Metrics
Total Assets
3.8B
Total Liabilities
1.1B
Shareholders Equity
2.6B
Debt to Equity
0.42
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Gujarat Themis Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.5B | 1.7B | 1.5B | 1.1B | 904.2M |
| Cost of Goods Sold | 318.8M | 416.1M | 307.8M | 208.9M | 211.1M |
| Gross Profit | 1.2B | 1.3B | 1.2B | 933.0M | 693.2M |
| Gross Margin % | 78.9% | 75.5% | 79.2% | 81.7% | 76.7% |
| Operating Expenses | |||||
| Research & Development | 34.4M | 38.9M | 29.3M | 4.5M | 0 |
| Selling, General & Administrative | 25.7M | 17.6M | 24.5M | 11.2M | 8.5M |
| Other Operating Expenses | 341.3M | 333.4M | 297.0M | 263.4M | 199.2M |
| Total Operating Expenses | 401.3M | 389.8M | 350.8M | 279.1M | 207.8M |
| Operating Income | 642.5M | 755.3M | 725.1M | 565.7M | 395.5M |
| Operating Margin % | 42.6% | 44.5% | 49.0% | 49.5% | 43.7% |
| Non-Operating Items | |||||
| Interest Income | 7.1M | 40.4M | 51.3M | 32.6M | 21.5M |
| Interest Expense | 2.3M | 1.4M | 948.0K | 7.3M | 7.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 655.4M | 793.3M | 774.6M | 590.3M | 408.8M |
| Income Tax | 167.7M | 201.7M | 195.0M | 154.1M | 107.0M |
| Effective Tax Rate % | 25.6% | 25.4% | 25.2% | 26.1% | 26.2% |
| Net Income | 487.7M | 591.6M | 579.7M | 436.2M | 301.8M |
| Net Margin % | 32.3% | 34.8% | 39.1% | 38.2% | 33.4% |
| Key Metrics | |||||
| EBITDA | 713.0M | 835.4M | 801.4M | 620.5M | 434.0M |
| EPS (Basic) | ₹4.48 | ₹5.43 | ₹5.32 | ₹4.00 | ₹2.77 |
| EPS (Diluted) | ₹4.48 | ₹5.43 | ₹5.32 | ₹4.00 | ₹2.77 |
| Basic Shares Outstanding | 108965265 | 108965265 | 108965265 | 108965265 | 108965265 |
| Diluted Shares Outstanding | 108965265 | 108965265 | 108965265 | 108965265 | 108965265 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Gujarat Themis Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 116.9M | 64.7M | 60.5M | 2.6M | 39.7M |
| Short-term Investments | 18.5M | 81.1M | 28.5M | 216.1M | 362.3M |
| Accounts Receivable | 312.4M | 270.3M | 179.1M | 251.2M | 147.1M |
| Inventory | 50.5M | 33.3M | 146.2M | 116.1M | 60.5M |
| Other Current Assets | 21.4M | 8.7M | 1.0K | 4.0K | 2.9M |
| Total Current Assets | 519.7M | 475.6M | 617.3M | 783.9M | 633.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 411.3M | 14.7M | 22.6M | 22.6M | 22.6M |
| Goodwill | 1.6M | - | - | - | - |
| Intangible Assets | 1.6M | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 3.1M | 9.1M | 1.0M | 1.2M | 6.4M |
| Total Non-Current Assets | 2.5B | 1.7B | 1.0B | 441.1M | 249.4M |
| Total Assets | 3.0B | 2.2B | 1.7B | 1.2B | 882.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 146.5M | 99.1M | 95.4M | 66.2M | 35.4M |
| Short-term Debt | 8.3M | 15.4M | 4.2M | 7.5M | 38.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 2.1M | 10.6M | 15.2M | 25.5M | 7.5M |
| Total Current Liabilities | 205.6M | 161.6M | 152.8M | 171.6M | 158.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 296.4M | 12.2M | 0 | 4.2M | 10.0M |
| Deferred Tax Liabilities | 19.6M | 16.6M | 13.0M | 10.2M | 9.8M |
| Other Non-Current Liabilities | - | -1.0K | -1.0K | -2.0K | -1.0K |
| Total Non-Current Liabilities | 323.7M | 35.8M | 19.0M | 20.2M | 24.9M |
| Total Liabilities | 529.3M | 197.4M | 171.8M | 191.8M | 183.2M |
| Equity | |||||
| Common Stock | 109.0M | 72.6M | 72.6M | 72.6M | 72.6M |
| Retained Earnings | 2.4B | 1.9B | 1.4B | 937.4M | 603.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.5B | 2.0B | 1.5B | 1.0B | 699.5M |
| Key Metrics | |||||
| Total Debt | 304.7M | 27.7M | 4.2M | 11.7M | 48.3M |
| Working Capital | 314.1M | 314.0M | 464.5M | 612.3M | 475.0M |
Balance Sheet Composition
Gujarat Themis Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 655.4M | 793.3M | 774.6M | 590.3M | 408.8M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 319.6M | 37.0M | -181.0M | -75.9M | -161.8M |
| Operating Cash Flow | 970.7M | 795.1M | 543.8M | 491.4M | 227.3M |
| Investing Activities | |||||
| Capital Expenditures | -1.2B | -746.4M | -237.0M | -139.0M | -30.5M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | 0 | 50.0K |
| Investing Cash Flow | -1.2B | -746.4M | -237.0M | -139.0M | -30.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -18.2M | -69.0M | -124.4M | -100.0M | -24.0M |
| Debt Issuance | 298.9M | - | - | - | 0 |
| Debt Repayment | - | - | 0 | -30.7M | -20.1M |
| Financing Cash Flow | 280.7M | -69.0M | -124.4M | -130.7M | -44.1M |
| Free Cash Flow | -251.2M | -104.3M | 157.7M | 264.2M | 74.7M |
| Net Change in Cash | 89.9M | -20.4M | 182.5M | 221.7M | 152.8M |
Cash Flow Trend
Gujarat Themis Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
73.73
Price to Book
13.36
Price to Sales
22.23
PEG Ratio
-17.55
Profitability Ratios
Profit Margin
29.99%
Operating Margin
40.16%
Return on Equity
19.64%
Return on Assets
16.19%
Financial Health
Current Ratio
1.47
Debt to Equity
27.04
Beta
-0.17
Per Share Data
EPS (TTM)
₹4.40
Book Value per Share
₹24.29
Revenue per Share
₹14.62
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GUJTHEM | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Aarti Drugs | 34.0B | 16.37 | 2.43 | 12.28% | 8.03% | 39.05 |
Financial data is updated regularly. All figures are in the company's reporting currency.





